Antiulcerants
| Drug | Dosage | Remarks |
|---|---|---|
| Bismuth Preparations | ||
| Bismuth subsalicylate | 524 mg PO 12 hourly with 2 antibiotics and 1 PPI x 10-14 days |
Adverse Reactions
|
| Bismuth subcitrate (Bismuth subcitrate [colloidal], Tripotassium dicitrato bismuthate)1 | 120 mg PO 6 hourly in combination with other drugs x 2 weeks | |
| Histamine2-Receptor Antagonist (H2RA) | ||
| Ranitidine |
Duodenal ulcer associated with H pylori infection: 300 mg PO once nightly or 150 mg PO 12 hourly with Amoxicillin and Metronidazole x 14 days or 50 mg slow IV 6-8 hourly |
Adverse Reactions
|
| Potassium-Competitive Acid Blockers (PCABs) | ||
| Tegoprazan | 50 mg PO 12 hourly x 7 days |
Adverse Reactions
|
| Vonoprazan | 20 mg PO 12 hourly x 7 days |
Adverse Reactions
|
| Proton Pump Inhibitors (PPIs) | ||
| Esomeprazole | 20 mg PO 12 hourly or 40 mg PO 24 hourly |
Adverse Reactions
|
| Lansoprazole | 30 mg PO 12 hourly | |
| Omeprazole2 | 20 mg PO 12 hourly or 40 mg PO 24 hourly or 40 mg IV bolus 24 hourly x 5 days | |
| Pantoprazole | 40 mg PO 12 hourly | |
| Rabeprazole (Na rabeprazole, Sodium rabeprazole) |
10-20 mg PO 12 hourly | |
| Combination Products | ||
| Amoxicillin/Clarithromycin/Pantoprazole |
Amoxicillin 1 g/Clarithromycin 500 mg/Pantoprazole 40 mg 1 tab of each drug PO 12 hourly x 1-2 weeks |
Adverse Reactions
|
| Clarithromycin/Metronidazole/Omeprazole |
Clarithromycin 250 mg/Metronidazole 400 mg/Omeprazole 20 mg 1 tab/cap of each drug PO 12 hourly x 1-2 weeks |
• See Remarks section of each individual drug component for the Adverse Reactions and Special Instructions |
| Clarithromycin/Tinidazole/Omeprazole |
Clarithromycin 250 mg/Tinidazole 500 mg/Omeprazole 20 mg 1 tab of each drug PO 12 hourly x 1 week |
|
|
1Combination with other anti-H pylori products is available. Please see the latest MIMS for specific formulations and prescribing information. 2Combination with Sodium bicarbonate is available. Please see the latest MIMS for specific formulations and prescribing information. |
||
Macrolide
| Drug | Dosage | Remarks |
|---|---|---|
| Clarithromycin | 500 mg PO 12 hourly | Adverse Reactions
|
Other Antibiotics
| Drug | Dosage | Remarks |
|---|---|---|
| Nitroimidazole Derivatives | ||
| Metronidazole | 400-500 mg PO 12 hourly or 500 mg IV 8 hourly x 7 days |
Adverse Reactions
|
| Tinidazole | 500 mg PO 12 hourly | Adverse Reactions
|
Penicillins
| Drug | Dosage | Remarks |
|---|---|---|
| Amoxicillin | 1,000 mg PO 12 hourly | Adverse Reactions
|
| Amoxicillin/clavulanic acid (Co-amoxiclav, Amoxicillin/ clavulanate) |
250-500 mg PO 8 hourly |
Quinolone
| Drug | Dosage | Remarks |
|---|---|---|
| Levofloxacin | 500 mg PO 24 hourly | Adverse Reactions
|
Supplements & Adjuvant Therapy
| Drug | Dosage | Remarks |
|---|---|---|
| Fucoidan | 50 mg PO 12 hourly or 100 mg PO 24 hourly |
Special Instructions
|
| Lactobacillus reuteri | 200 mg PO 24 hourly or 900 mg PO 24 hourly or 1,400 mg PO 24 hourly |
Special Instructions
|
Tetracycline
| Drug | Dosage | Remarks |
|---|---|---|
| Tetracycline | 500 mg PO 6 hourly |
Adverse Reactions
|
Disclaimer
All dosage recommendations are for non-pregnant and non-breastfeeding women, and non-elderly adults with normal renal and hepatic function unless otherwise stated.
Not all products are available or approved for above use in all countries.
Products listed in the Drug Summary are based on indications stated in the locally approved product monographs.
Please refer to local product monographs in Related MIMS Drugs for country-specific prescribing information.
Not all products are available or approved for above use in all countries.
Products listed in the Drug Summary are based on indications stated in the locally approved product monographs.
Please refer to local product monographs in Related MIMS Drugs for country-specific prescribing information.
